On ECHEMI
Home > Drugs > Compound Danzhi Tablets

Compound Danzhi Tablets

Function and Efficacy

The results of animal experiments indicate that oral administration of this product can counteract the increased cerebral vascular permeability after cerebral ischemia in rats with ligation of bilateral common carotid arteries, reduce brain water content, and alleviate brain atrophy-like changes caused by ischemia; it can inhibit arterial thrombosis in rats, reduce the platelet adhesion rate in rats, inhibit ADP-induced platelet aggregation, shorten the euglobulin lysis time, and reduce the blood viscosity, hematocrit and fibrinogen in rats with dexamethasone-induced "blood stasis" model.

Ingredients

Astragalus, Salvia miltiorrhiza, Leech, Pheretima, and Ligusticum chuanxiong.

Name Description Content CAS NO. Manufacturer
RiligustilideIngredients

It can counteract the increased cerebral vascular permeability after cerebral ischemia, reduce brain water content, and alleviate brain atrophy-like changes caused by ischemia; inhibit arterial thrombosis, reduce platelet adhesion rate, inhibit ADP-induced platelet aggregation, shorten euglobulin lysis time, and reduce blood viscosity, hematocrit and fibrinogen.

More
89354-45-0 0

Appearance

This product is a film-coated tablet. After removing the film coating, it appears brown in color. It tastes bitter and slightly astringent.

Usage and Dosage

Oral administration: 5 tablets at a time, 3 times a day, for 6 weeks.

Adverse Reactions

In some cases, abdominal pain occurred after taking the medicine.

Precautions

It is not suitable for patients with cerebral hemorrhage or pregnant women.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

Sealed and moisture-proof.

Packaging Specification

Each tablet core weight 0.35g (sugar-coated tablet); each tablet weight 0.36g (film-coated tablet)

Validity Period

24 months

Manufacturer

Tonghua Baishan Pharmaceutical Stock Co., Ltd.

  • Founded in:

    1999-04-08
  • Address:

    Jilin Province Tonghua Wanwanchuan Development Zone
  • Tax NO.:

    91220501702337222J
  • Registered Funds:

    33 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.